Nusano to Present at Jefferies Radiopharma Innovation Summit
VALENCIA, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of medical radioisotopes, today announced it will attend and present at Jefferies Radiopharma Innovation Summit in New York City on Thursday, April 11, 2024.
- VALENCIA, Calif., April 10, 2024 (GLOBE NEWSWIRE) -- Nusano, a physics company transforming the production of medical radioisotopes, today announced it will attend and present at Jefferies Radiopharma Innovation Summit in New York City on Thursday, April 11, 2024.
- In his presentation, Nusano CEO Chris Lowe will provide an update on the company’s commercialization plans, including programs to make lutetium-177 and actinium-225 available on a commercial scale in 2025.
- Nusano management will also be available for 1-on-1 meetings.
- To request a meeting, qualified investors should contact their Jefferies representative or email [email protected] .